IRIS
BURLANDO, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.819
NA - Nord America 1.493
AS - Asia 1.254
Continente sconosciuto - Info sul continente non disponibili 210
SA - Sud America 128
AF - Africa 20
Totale 10.924
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 7.612
US - Stati Uniti d'America 1.401
SG - Singapore 449
CN - Cina 332
VN - Vietnam 223
BD - Bangladesh 117
FR - Francia 87
BR - Brasile 78
HK - Hong Kong 40
CA - Canada 29
DE - Germania 28
GB - Regno Unito 25
AR - Argentina 24
FI - Finlandia 16
CO - Colombia 14
JM - Giamaica 14
CH - Svizzera 12
JP - Giappone 12
MX - Messico 12
IN - India 10
IQ - Iraq 10
ES - Italia 8
GT - Guatemala 8
ID - Indonesia 8
PK - Pakistan 8
CR - Costa Rica 7
NL - Olanda 7
PH - Filippine 7
ZA - Sudafrica 6
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
EC - Ecuador 4
HN - Honduras 4
IE - Irlanda 4
TT - Trinidad e Tobago 4
AL - Albania 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
LB - Libano 3
NI - Nicaragua 3
RO - Romania 3
RU - Federazione Russa 3
AZ - Azerbaigian 2
BB - Barbados 2
CL - Cile 2
DZ - Algeria 2
IL - Israele 2
KE - Kenya 2
MA - Marocco 2
MM - Myanmar 2
NP - Nepal 2
PS - Palestinian Territory 2
TH - Thailandia 2
UA - Ucraina 2
AT - Austria 1
BE - Belgio 1
BF - Burkina Faso 1
BH - Bahrain 1
BS - Bahamas 1
CV - Capo Verde 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KY - Cayman, isole 1
LT - Lituania 1
LY - Libia 1
ML - Mali 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PL - Polonia 1
PR - Porto Rico 1
PY - Paraguay 1
RE - Reunion 1
RS - Serbia 1
SE - Svezia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TR - Turchia 1
TW - Taiwan 1
Totale 10.714
Salva come PNG Salva come JPEG
Città #
Genova 3.014
Genoa 2.970
Vado Ligure 775
Rapallo 662
San Jose 331
Ashburn 207
Singapore 193
Lauterbourg 79
Beijing 74
Ho Chi Minh City 74
Council Bluffs 55
Hanoi 45
New York 38
Hong Kong 37
Santa Clara 36
Bordighera 26
Los Angeles 24
Frankfurt am Main 23
Boardman 21
Milan 20
Rome 19
Haiphong 16
Helsinki 16
Da Nang 14
Atlanta 12
Tokyo 12
Orem 11
St Louis 11
Phoenix 10
São Paulo 10
Houston 9
Zurich 9
Mexico City 8
San Francisco 8
Washington 8
Brooklyn 7
Chicago 7
Dallas 7
Des Moines 7
Montreal 7
Bogotá 6
Buffalo 6
City of London 6
Guatemala City 6
Kingston 6
San José 6
Toronto 6
Denver 5
Guangzhou 5
Naples 5
Philadelphia 5
San Antonio 5
Shanghai 5
Tashkent 5
Amsterdam 4
Baghdad 4
Biên Hòa 4
Brasília 4
Dhaka 4
Las Vegas 4
London 4
Louisville 4
Miami 4
Montoro 4
Rochester 4
Turin 4
Bari 3
Beaumont 3
Berlin 3
Bologna 3
Boston 3
Boydton 3
Detroit 3
El Paso 3
Ha Long 3
Hartford 3
Hayes 3
Islington 3
Jackson 3
Jersey City 3
Johannesburg 3
Lahore 3
Madrid 3
Managua 3
Milwaukee 3
Minneapolis 3
North Little Rock 3
Osasco 3
Paris 3
Pasadena 3
Princeton 3
Quezon City 3
Quảng Ngãi 3
Quận Ba 3
Rudolfstetten 3
San Diego 3
The Bronx 3
Thái Bình 3
Trento 3
Allentown 2
Totale 9.138
Salva come PNG Salva come JPEG
Nome #
Le cheratosi attiniche nei pazienti con trombocitemia in trattamento con idrossiurea; L'esperienza della clinica dermatologica nella gestione dei farmaci biologici nella psoriasi moderata grave; Angiosarcoma della mammella. 388
Essential Thrombocythemia: The Dermatologic Point of View 349
Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects 225
Latent tuberculosis infection in patients with chronic plaque psoriasis: Evidence from the Italian Psocare Registry 224
Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets 210
TNF-α gene polymorphisms: association with disease susceptibility and response to anti-TNF-α treatment in psoriatic arthritis 198
Adverse effects of biological agents in the treatment of psoriasis. 192
Bilateral Warthin tumor in psoriatic patients in therapy with multiple immunosuppressive therapy 172
Active pharmacovigilance program in patients affected by psoriasis and inflammatory bowel diseases
 165
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: Evidence from the Italian Psocare Registry 165
Atopic-like dermatitis after secukinumab injection: A case report 154
Different Responses to Ustekinumab of Two HLA-Cw6-positive Homozygous Twins with Psoriasis 153
Pruritus characteristics in a large Italian cohort of psoriatic patients 153
PSOdisk is a reliable, intuitive instrument for the evaluation of psychological distress, which strongly correlates with DLQI: a preliminary study 145
Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study 142
Narrow-band imaging: a useful tool for early recognition of oral lichen planus malignant transformation? 139
Primary cutaneous melanoma: Correlation between clinical and histologic aspects in a retrospective Italian study 138
Generalized annular granuloma associated with crowned dens syndrome, which resolved with colchicine treatment 135
Psoriasis as a cardiovascular risk factor: Updates and algorithmic approach 135
Cutaneous manifestations of HAV, HBV, HCV 134
Cutaneous manifestations of hematologic malignancies the experience of an Italian dermatology department 134
Un cas de cryptococcose cutanèe primitive sans diffusion systemique chez un patient immunodeprimé 133
The management of Autoimmune diseases in preconception, pregnancy and lactation 132
Biological therapy in genital psoriasis in women 129
Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry 128
Autoantibody Profile of a Cohort of 78 Italian Patients with Mucous Membrane Pemphigoid: Correlation Between Reactivity Profile and Clinical Involvement 127
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 127
The HLA-Cw6 Dilemma: Is It Really an Outcome Predictor in Psoriasis Patients under Biologic Therapy? A Monocentric Retrospective Analysis 124
Institution of an interdisciplinary IBD centre is associated with improved healthcare utilisation 120
An unusual case of bullous haemorrhagic vasculitis in a COVID-19 patient 120
Papular elastolytic giant cell granuloma: report of a case associated with monoclonal gammopathy and responsive to topical tacrolimus. 120
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study 119
Comedonal variant of chronic cutaneous lupus erythematosus causing mutilation of the earlobe 119
Usefulness of Dermoscopy in Eruptive Syringomas in an Elderly Woman 117
A purplish plaque and multiple nodules on the arm 116
Ciprofloxacin as a Trigger for Bullous Pemphigoid: The Second Case in the Literature 116
Role of high-resolution ultrasound in the evaluation of psoriatic onychopathy 114
Could Terra firma-forme dermatosis induce eczematous halo dermatitis? An hypothesis 114
Acetazolamide: a new trigger for bullous pemphigoid? 113
Atypical and Rare Forms of Cutaneous Lupus Erythematosus: The Importance of the Diagnosis for the Best Management of Patients 113
Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: A relevant class-effect 112
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study 109
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience 108
Erythema multiforme after initiation of anti interleukin-12/23 (ustekinumab) treatment for plaque psoriasis 107
Acute urticarial rash after covid-19 vaccination containing polysorbate 80 107
Ashy dermatosis-like hyperpigmentation: not always the omeprazole's fault 106
"De Novo" Psoriasis and Relapse of Psoriasis Induced by Dupilumab: Three New Cases and Review of the Literature 104
Switching from Secukinumab to Ustekinumab in Psoriasis Patients: Results from a Multicenter Experience 102
Can Methotrexate be a successful treatment for unresponsive generalized annular elastolytic giant cell granuloma? Case report and review of the literature 102
Vasculitis associated with connective tissue diseases 97
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy 97
Dermatoskopisch kontrollierte, schmalere Resektionsränder bei Basalzellkarzinomen an Kopf und Hals: Retrospektive Fallkontrollstudie 96
A survey of psoriasis patients on biologics during COVID-19: a single centre experience 96
The STRIPP questionnaire (Screening Tool for Rheumatologic Investigation in Psoriatic Patients) as a new tool for the diagnosis of early psoriatic arthritis 95
Cutaneous reactions to COVID-19 vaccine at the dermatology primary care 95
Detection of antibodies to anti-TNF agents in psoriatic patients: a preliminary study. 93
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study 91
Cutaneous reactions to COVID-19 vaccine at the dermatology primary care 91
Effects of TNF-α inhibitors in patients with psoriasis and metabolic syndrome: a preliminary study 90
Consensus on the place in therapy of TNF-α inhibitors in the treatment of patients with chronic plaque psoriasis 90
Guselkumab-associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature 90
The quality of life in Italian psoriatic patients treated with biological drugs. 86
Serial biologic therapies in psoriasis patients: A 12-year, single-center, retrospective observational study 86
COVID-19 “second wave” and vaccines: the dermatologists’ perspective 86
Increased serum level of N-terminal Pro-B-type natriuretic peptide in psoriatic patients: a single-center study 85
Psoriasis patients' characteristics associated with high PASI response to tildrakizumab: an international dual center study 85
Dermatoscopically narrowed surgical margins for head and neck basal cell carcinoma: A retrospective case-control study 85
Bulky Condyloma Acuminata following Ustekinumab Treatment for Plaque Psoriasis: A Case Report 84
Considerations on inhibition of IL-23 in psoriatic women of childbearing potential 84
Cutaneous effects of antihypertensive drugs 83
Lichen planus flare following COVID-19 vaccination: A case report 82
Study of efficacy and safety of rucinol and sophora alpha in the topical treatment of cutaneous hypermelanoses 81
Reticular Erythematous Mucinosis: Exclusive Involvement of the Axillary Region 79
Inflammatory/infectious cutaneous side effects of biological drugs in patients with psoriasis: a general review with personal data 78
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review 78
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study 77
Epstein-Barr virus reactivation after COVID-19 vaccination in a young immunocompetent man: a case report 75
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients 73
Severe Generalized Pustular Psoriasis Successfully Treated with Ixekizumab: A Case Report 70
Differenti risposte a Ustekinumab in due gemelli omozigoti HLA-CW6 positivi affetti da psoriasi 70
The 30th birthday of chronic ulcerative stomatitis: A systematic review 69
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing 67
Pruritic erythematous macules in a patient with systemic sarcoidosis: A quiz 65
Dimethyl fumarate-associated ashy dermatosis 64
Deferred time of delivery of biologic therapies in patients with stabilized psoriasis leads to a 'perceived satisfaction': a multicentric study 64
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 63
Six months into the pandemic. A review of skin manifestations in SARS-CoV-2 infection 61
Does psoriasis influence female sexual dysfunction? A multicentric Italian case-control study 60
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis) 58
Crushed corticosteroid tablets in peristomal pyoderma gangrenosum: A case report 58
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS) 57
Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting 57
Early predictors of psoriatic arthritis: a Delphi-based consensus from Italian dermatology centers 50
Italian expert-based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides: Results of an e-Delphi consensus 49
A Mobile App to Enhance Awareness of Vaccination in Adults With Psoriasis and Atopic Dermatitis: Development and Preliminary Evaluation Study (Preprint) 47
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study 46
A Mobile App to Enhance Awareness of Vaccination in Adults With Psoriasis and Atopic Dermatitis: Development and Preliminary Evaluation Study 46
null 43
Four-years experience with the preferential derivation care model for multidisciplinary care in patients with psoriasis and psoriatic arthritis 42
Linear atrophoderma of Moulin and atrophoderma of Pasini and Pierini. The relevance of ultrasound imaging in the initial assessment 36
Totale 10.858
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.989
article - articoli 43.467
book - libri 0
conference - conferenze 1.522
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.978
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022793 0 0 28 74 35 117 12 184 85 109 24 125
2022/2023811 77 66 16 76 109 109 9 51 171 15 101 11
2023/2024901 33 75 37 102 67 147 56 118 18 59 110 79
2024/20251.989 70 136 47 136 260 199 169 323 65 99 204 281
2025/20263.307 387 80 160 250 451 221 548 170 263 291 202 284
2026/2027779 321 295 163 0 0 0 0 0 0 0 0 0
Totale 10.924